Single nucleotide polymorphisms of CD20 gene and their relationship with clinical efficacy of R-CHOP in patients with diffuse large B cell lymphoma

citation_journal_title=Biotechniques; citation_title=Pharmacogenetics and pharmacogenomics in oncology therapeutic antibody development; citation_author=L Yan, RA Beckman; citation_volume=39; citation_issue=4; citation_publication_date=2005; citation_pages=565-568; citation_doi=10.2144/000112043; citation_id=CR1 citation_journal_title=Blood; citation_title=Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcgammaRIIIa gene; citation_author=G Cartron, L Dacheux, G Salles, P Solal-Celigny, P Bardos, P Colombat, H Watier; citation_volume=99; citation_issue=3; citation_publication_date=2002; citation_pages=754-758; citation_doi=10.1182/blood.V99.3.754; citation_id=CR2 citation_journal_title=Ann Oncol; citation_title=Role of the HER2 [Ile655Val] genetic polymorphism in tumorogenesis and in the risk of trastuzumab-related cardiotoxicity; citation_author=S Beauclair, P Formento, JL Fischel, W Lescaut, R Largillier, E Chamorey, P Hofman, JM Ferrero, G Pages, G Milano; citation_volume=18; citation_issue=8; citation_publication_date=2007; citation_pages=1335-1341; citation_doi=10.1093/annonc/mdm181; citation_id=CR3 citation_journal_title=Blood; citation_title=IDEC-C2B8 (Rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma; citation_author=DG Maloney, AJ Grillo-Lopez, CA White, D Bodkin, RJ Schilder, JA Neidhart, N Janakiraman, KA Foon, TM Liles, BK Dallaire; citation_volume=90; citation_issue=6; citation_publication_date=1997; citation_pages=2188-2195; citation_id=CR4 citation_journal_title=Blood; citation_title=Phase I clinical trial using escalating single-dose infusion of chimeric anti-CD20 monoclonal antibody (IDEC-C2B8) in patients with recurrent B-cell lymphoma; citation_author=DG Maloney, TM Liles, DK Czerwinski, C Waldichuk, J Rosenberg, A Grillo-Lopez, R Levy; citation_volume=84; citation_issue=8; citation_publication_date=1994; citation_pages=2457-2466; citation_id=CR5 citation_journal_title=Blood; citation_title=Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20; citation_author=ME Reff, K Carner, KS Chambers, PC Chinn, JE Leonard, R Raab, RA Newman, N Hanna, DR Anderson; citation_volume=83; citation_issue=2; citation_publication_date=1994; citation_pages=435-445; citation_id=CR6 citation_journal_title=Cancer Cell Int; citation_title=Rituximab and new regimens for indolent lymphoma: a brief update from 2012 ASCO Annual Meeting; citation_author=J Zhao, Z Xu, D Liu, Q Lu; citation_volume=12; citation_issue=1; citation_publication_date=2012; citation_pages=38-42; citation_doi=10.1186/1475-2867-12-38; citation_id=CR7 citation_journal_title=J Clin Oncol; citation_title=Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma; citation_author=TM Habermann, EA Weller, VA Morrison, RD Gascoyne, PA Cassileth, JB Cohn, SR Dakhil, B Woda, RI Fisher, BA Peterson; citation_volume=24; citation_issue=19; citation_publication_date=2006; citation_pages=3121-3127; citation_doi=10.1200/JCO.2005.05.1003; citation_id=CR8 citation_journal_title=N Eng J Med; citation_title=Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma; citation_author=RI Fisher, ER Gaynor, S Dahlberg, MM Oken, TM Grogan, EM Mize, JH Glick, CA Coltman, TP Miller; citation_volume=328; citation_issue=14; citation_publication_date=1993; citation_pages=1002-1006; citation_doi=10.1056/NEJM199304083281404; citation_id=CR9 citation_journal_title=J Clin Oncol; citation_title=State-of-the-art therapeutics: diffuse large B-cell lymphoma; citation_author=B Coiffier; citation_volume=23; citation_issue=26; citation_publication_date=2005; citation_pages=6387-6393; citation_doi=10.1200/JCO.2005.05.015; citation_id=CR10 citation_journal_title=Exp Hematol Oncol; citation_title=R-CHOP with dose-attenuated radiation therapy could induce good prognosis in gastric diffuse large B cell lymphoma; citation_author=Y Mishima, Y Terui, M Yokoyama, N Nishimura, S Sakajiri, K Ueda, Y Kuboki, K Nakano, K Suzuki, E Nara; citation_volume=1; citation_issue=1; citation_publication_date=2012; citation_pages=30-35; citation_doi=10.1186/2162-3619-1-30; citation_id=CR11 citation_journal_title=Exp Hematol Oncol; citation_title=CD19: a biomarker for B cell development, lymphoma diagnosis and therapy; citation_author=K Wang, G Wei, D Liu; citation_volume=1; citation_issue=1; citation_publication_date=2012; citation_pages=36-42; citation_doi=10.1186/2162-3619-1-36; citation_id=CR12 citation_journal_title=Semin Hematol; citation_title=CD20 as a target for therapeutic type I and II monoclonal antibodies; citation_author=SA Beers, CH Chan, RR French, MS Cragg, MJ Glennie; citation_volume=47; citation_issue=2; citation_publication_date=2010; citation_pages=107-114; citation_doi=10.1053/j.seminhematol.2010.01.001; citation_id=CR13 citation_journal_title=J Biol Chem; citation_title=Structural basis for recognition of CD20 by therapeutic antibody Rituximab; citation_author=J Du, H Wang, C Zhong, B Peng, M Zhang, B Li, S Huo, Y Guo, J Ding; citation_volume=282; citation_issue=20; citation_publication_date=2007; citation_pages=15073-15080; citation_doi=10.1074/jbc.M701654200; citation_id=CR14 citation_journal_title=J Hematol Oncol; citation_title=Novel CD20 monoclonal antibodies for lymphoma therapy; citation_author=S Cang, N Mukhi, K Wang, D Liu; citation_volume=5; citation_publication_date=2012; citation_pages=64-72; citation_doi=10.1186/1756-8722-5-64; citation_id=CR15 citation_journal_title=Leuk Res; citation_title=Mutation or polymorphism of the CD20 gene is not associated with the response to R-CHOP in diffuse large B cell lymphoma patients; citation_author=A Sar, M Perizzolo, D Stewart, A Mansoor, LM Difrancesco, DJ Demetrick; citation_volume=33; citation_issue=6; citation_publication_date=2009; citation_pages=792-797; citation_doi=10.1016/j.leukres.2008.10.013; citation_id=CR16 citation_journal_title=Haematologica; citation_title=CD20 mutations involving the rituximab epitope are rare in diffuse large B-cell lymphomas and are not a significant cause of R-CHOP failure; citation_author=NA Johnson, S Leach, B Woolcock, RJ DeLeeuw, A Bashashati, LH Sehn, JM Connors, M Chhanabhai, A Brooks-Wilson, RD Gascoyne; citation_volume=94; citation_issue=3; citation_publication_date=2009; citation_pages=423-427; citation_doi=10.3324/haematol.2008.001024; citation_id=CR17 citation_journal_title=J Clin Oncol; citation_title=Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas; citation_author=BD Cheson, SJ Horning, B Coiffier, MA Shipp, RI Fisher, JM Connors, TA Lister, J Vose, A Grillo-Lopez, A Hagenbeek; citation_volume=17; citation_issue=4; citation_publication_date=1999; citation_pages=1244-1253; citation_id=CR18 citation_journal_title=Curr Dir Autoimmun; citation_title=The biology of CD20 and its potential as a target for mAb therapy; citation_author=MS Cragg, CA Walshe, AO Ivanov, MJ Glennie; citation_volume=8; citation_publication_date=2005; citation_pages=140-174; citation_doi=10.1159/000082102; citation_id=CR19 citation_journal_title=Clin Canc Res; citation_title=Identification of CD20 C-terminal deletion mutations associated with loss of CD20 expression in non-Hodgkin's lymphoma; citation_author=Y Terui, Y Mishima, N Sugimura, K Kojima, T Sakurai, Y Mishima, R Kuniyoshi, A Taniyama, M Yokoyama, S Sakajiri; citation_volume=15; citation_issue=7; citation_publication_date=2009; citation_pages=2523-2530; citation_doi=10.1158/1078-0432.CCR-08-1403; citation_id=CR20 citation_journal_title=Genome Biol Evol; citation_title=Weak 5'-mRNA secondary structures in short eukaryotic genes; citation_author=Y Ding, P Shah, JB Plotkin; citation_volume=4; citation_issue=10; citation_publication_date=2012; citation_pages=1046-1053; citation_doi=10.1093/gbe/evs082; citation_id=CR21 citation_journal_title=Science; citation_title=A "silent" polymorphism in the MDR1 gene changes substrate specificity; citation_author=C Kimchi-Sarfaty, JM Oh, IW Kim, ZE Sauna, AM Calcagno, SV Ambudkar, MM Gottesman; citation_volume=315; citation_issue=5811; citation_publication_date=2007; citation_pages=525-528; citation_doi=10.1126/science.1135308; citation_id=CR22 citation_journal_title=Hum Mol Genet; citation_title=Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor; citation_author=J Duan, MS Wainwright, JM Comeron, N Saitou, AR Sanders, J Gelernter, PV Gejman; citation_volume=12; citation_issue=3; citation_publication_date=2003; citation_pages=205-216; citation_doi=10.1093/hmg/ddg055; citation_id=CR23 citation_journal_title=Proc Natl Acad Sci USA; citation_title=Synergistic effects of genetic variation in nicotinic and muscarinic receptors on visual attention but not working memory; citation_author=PM Greenwood, MK Lin, R Sundararajan, KJ Fryxell, R Parasuraman; citation_volume=106; citation_issue=9; citation_publication_date=2009; citation_pages=3633-3638; citation_doi=10.1073/pnas.0807891106; citation_id=CR24 citation_journal_title=Nat Rev Genet; citation_title=Hearing silence: non-neutral evolution at synonymous sites in mammals; citation_author=JV Chamary, JL Parmley, LD Hurst; citation_volume=7; citation_issue=2; citation_publication_date=2006; citation_pages=98-108; citation_doi=10.1038/nrg1770; citation_id=CR25 citation_journal_title=J Clin Oncol; citation_title=WT1 synonymous single nucleotide polymorphism rs16754 correlates with higher mRNA expression and predicts significantly improved outcome in favourable-risk paediatric acute myeloid leukaemia: a report from the children's oncology group; citation_author=PA Ho, J Kuhn, RB Gerbing, JA Pollard, R Zeng, KL Miller, NA Heerema, SC Raimondi, BA Hirsch, JL Franklin; citation_volume=29; citation_issue=6; citation_publication_date=2011; citation_pages=704-711; citation_doi=10.1200/JCO.2010.31.9327; citation_id=CR26